TRIM9, tripartite motif containing 9, 114088

N. diseases: 24; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Other and unspecified reactive psychosis
0.100 GeneticVariation disease GWASCAT Genome-wide association study of atypical psychosis. 24132900 2013
CUI: C0033975
Disease: Psychotic Disorders
Psychotic Disorders
0.100 GeneticVariation group GWASCAT Genome-wide association study of atypical psychosis. 24132900 2013
CUI: C0027404
Disease: Narcolepsy
Narcolepsy
0.100 GeneticVariation disease GWASDB Genome-wide association database developed in the Japanese Integrated Database Project. 19629137 2009
CUI: C0026896
Disease: Myasthenia Gravis
Myasthenia Gravis
0.010 Biomarker disease BEFREE There was a decrease in thymocyte miR-653 and an increase in TRIM9 in thymic tissues of MG mice. miR-653 was found to negatively regulate TRIM9. 30703767 2019
CUI: C0038443
Disease: Stress, Psychological
Stress, Psychological
0.010 Biomarker disease BEFREE We therefore examined the contribution of childhood adversity through pregnancy and the first year of life to hair and salivary cortisol measures of early life stress in the India SPRING home visits cluster RCT which aims to improve early childhood development. 31174162 2019
CUI: C0085207
Disease: Gestational Diabetes
Gestational Diabetes
0.010 Biomarker phenotype BEFREE Probiotics for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Women: Findings From the SPRING Double-Blind Randomized Controlled Trial. 30659070 2019
Paraneoplastic Cerebellar Degeneration
0.010 Biomarker disease BEFREE TRIM9 and TRIM67 Are New Targets in Paraneoplastic Cerebellar Degeneration. 30350014 2019
CUI: C0948008
Disease: Ischemic stroke
Ischemic stroke
0.010 Biomarker disease BEFREE TRIM9-Mediated Resolution of Neuroinflammation Confers Neuroprotection upon Ischemic Stroke in Mice. 30970257 2019
CUI: C1859308
Disease: PREMATURE CENTROMERE DIVISION
PREMATURE CENTROMERE DIVISION
0.010 Biomarker disease BEFREE Anti-TRIM9 and anti-TRIM67 Abs appeared to be specific biomarkers of PCD and should be added to the panel of antigens tested when this is suspected. 30350014 2019
CUI: C4551720
Disease: Primary Ciliary Dyskinesia
Primary Ciliary Dyskinesia
0.010 Biomarker disease BEFREE Anti-TRIM9 and anti-TRIM67 Abs appeared to be specific biomarkers of PCD and should be added to the panel of antigens tested when this is suspected. 30350014 2019
CUI: C0005940
Disease: Bone Diseases
Bone Diseases
0.010 Biomarker group BEFREE We externally validated the 2008-SPRING and the 2013-SPRING models in a prospective cohort (n = 164) of patients who underwent surgery for metastatic bone disease in the extremities from May 2014 to May 2016, called the validation cohort. 30020148 2018
CUI: C0017636
Disease: Glioblastoma
Glioblastoma
0.010 Biomarker disease BEFREE Co-reduction of MKK6 and TRIM9s is significantly associated with overall poor survival of glioblastoma patients. 29669288 2018
Secondary malignant neoplasm of bone
0.010 Biomarker disease BEFREE We produced the 2013-SPRING model by adding to the 2008-SPRING model (n = 130) a cohort of patients from a consecutive institutional database of patients who underwent surgery for bone metastases in the extremities with bone resection and reconstruction between 2009 and 2013 at a highly specialized surgical center in Denmark (n = 140). 30020148 2018
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.010 Biomarker disease BEFREE Co-reduction of MKK6 and TRIM9s is significantly associated with overall poor survival of glioblastoma patients. 29669288 2018
CUI: C0280474
Disease: Childhood Glioblastoma
Childhood Glioblastoma
0.010 Biomarker disease BEFREE Co-reduction of MKK6 and TRIM9s is significantly associated with overall poor survival of glioblastoma patients. 29669288 2018
CUI: C1621958
Disease: Glioblastoma Multiforme
Glioblastoma Multiforme
0.010 Biomarker disease BEFREE Co-reduction of MKK6 and TRIM9s is significantly associated with overall poor survival of glioblastoma patients. 29669288 2018
Respiratory Syncytial Virus Infections
0.010 Biomarker group BEFREE The model considered the most recent evidence from Spanish observational and epidemiological studies on RSV infection: the FLIP II study provided hospital admission and Intensive Care Unit (ICU) admission rates; in-hospital mortality rate was drawn from an epidemiological study from 2004 to 2012; recurrent wheezing rates associated to RSV infection from SPRING study were adjusted by the evidence on the palivizumab effect from clinical trials. 29041909 2017
CUI: C0043144
Disease: Wheezing
Wheezing
0.010 AlteredExpression phenotype BEFREE The model considered the most recent evidence from Spanish observational and epidemiological studies on RSV infection: the FLIP II study provided hospital admission and Intensive Care Unit (ICU) admission rates; in-hospital mortality rate was drawn from an epidemiological study from 2004 to 2012; recurrent wheezing rates associated to RSV infection from SPRING study were adjusted by the evidence on the palivizumab effect from clinical trials. 29041909 2017
CUI: C0007131
Disease: Non-Small Cell Lung Carcinoma
Non-Small Cell Lung Carcinoma
0.010 AlteredExpression disease BEFREE In an effort to profile the expression patterns of TRIM superfamily in several non-small cell lung cancer (NSCLC) cell lines, we found that the expression of 10 TRIM genes including TRIM3, TRIM7, TRIM14, TRIM16, TRIM21, TRIM22, TRIM29, TRIM59, TRIM66 and TRIM70 was significantly upregulated in NSCLC cell lines compared with the normal human bronchial epithelial (HBE) cell line, whereas the expression of 7 other TRIM genes including TRIM4, TRIM9, TRIM36, TRIM46, TRIM54, TRIM67 and TRIM76 was significantly down-regulated in NSCLC cell lines compared with that in HBE cells. 26599082 2015
CUI: C2363741
Disease: HIV-1 infection
HIV-1 infection
0.010 GeneticVariation disease BEFREE Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial. 24074642 2013
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.010 Biomarker disease BEFREE Immunohistochemical examination revealed that TRIM9 is localized to the neurons in the normal mouse and human brain and that TRIM9 immunoreactivity is severely decreased in the affected brain areas in Parkinson's disease and dementia with Lewy bodies. 20085810 2010
CUI: C0752347
Disease: Lewy Body Disease
Lewy Body Disease
0.010 Biomarker disease BEFREE These results suggest that TRIM9 plays an important role in the regulation of neuronal functions and participates in pathological process of Lewy body disease through its ligase activity. 20085810 2010
CUI: C0007134
Disease: Renal Cell Carcinoma
Renal Cell Carcinoma
0.010 AlteredExpression disease BEFREE These genes (ACY1, WT1, SELENBP1, COBL, EFHD1, AGXT2L1, ALDH5A1, THEM2, ABCB1, FLJ14146, CSPG2, TRIM9 and HEY1) are good candidates for genes whose activity is changed upon the decrease of HNF4alpha in RCC. 16007190 2005
Conventional (Clear Cell) Renal Cell Carcinoma
0.010 AlteredExpression disease BEFREE These genes (ACY1, WT1, SELENBP1, COBL, EFHD1, AGXT2L1, ALDH5A1, THEM2, ABCB1, FLJ14146, CSPG2, TRIM9 and HEY1) are good candidates for genes whose activity is changed upon the decrease of HNF4alpha in RCC. 16007190 2005